HARBOUR INVESTMENTS, INC. - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 42 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$753
+43.4%
3000.0%0.00%
Q1 2023$525
-58.8%
3000.0%0.00%
Q4 2022$1,275
+27.5%
300
-76.9%
0.00%
Q3 2022$1,0000.0%1,3000.0%0.00%
Q2 2022$1,000
-66.7%
1,3000.0%0.00%
Q4 2021$3,000
-57.1%
1,3000.0%0.00%
Q3 2021$7,000
-30.0%
1,3000.0%0.00%
Q2 2021$10,000
+25.0%
1,3000.0%0.00%
Q1 2021$8,0001,3000.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 300,000$300,0000.08%
Polar Capital Holdings Plc 5,599,407$5,599,0000.03%
VANCE WEALTH, INC. 13,299$13,0000.01%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$39,0000.01%
BENDER ROBERT & ASSOCIATES 14,059$14,0000.01%
HoyleCohen, LLC 30,432$30,0000.00%
Inscription Capital, LLC 17,000$17,0000.00%
Ergoteles LLC 100,722$101,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 89,100$89,0000.00%
ADIRONDACK TRUST CO 2,500$3,0000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders